Ç¥ÁØÈ­ Âü¿©¾È³»

TTAÀÇ Ç¥ÁØÇöȲ

Ȩ > Ç¥ÁØÈ­ °³¿ä > TTAÀÇ Ç¥ÁØÇöȲ

Ç¥ÁعøÈ£ TTAK.KO-12.0381 ±¸Ç¥ÁعøÈ£
Á¦°³Á¤ÀÏ 2021-12-08 ÃÑÆäÀÌÁö 13
ÇѱÛÇ¥Áظí ÀÇ·á±â±â ½ÃÆÇ ÈÄ »çÀ̹ö º¸¾È Ãë¾àÁ¡ ´ëÀÀ ÀýÂ÷
¿µ¹®Ç¥Áظí Cybersecurity Vulnerabilities Countermeasuring Process for Medical Device Postmarket
Çѱ۳»¿ë¿ä¾à º» Ç¥ÁØÀº ÀÇ·á±â±â ½ÃÆÇ ÈÄ ¹ß»ýÇϰųª ¹ß»ýÇÒ ¼ö ÀÖ´Â »çÀ̹ö º¸¾È Ãë¾àÁ¡ ´ëÀÀÀ» À§ÇÑ ÀýÂ÷¸¦ ¸ð´ÏÅ͸µ, Ãë¾àÁ¡ °³¼±, Á¤º¸°øÀ¯, Áö¿ø Á¾·á ´Ü°è·Î ±¸ºÐÇÏ¿© ÀÇ·á±â±â Á¦Á¶»ç°¡ ÀÇ·á±â±â ½ÃÆÇ ÈÄ ¼öÇàÇØ¾ß ÇÏ´Â »çÀ̹ö º¸¾È Ãë¾àÁ¡ ´ëÀÀ È°µ¿À» Á¦½ÃÇÑ´Ù.
¿µ¹®³»¿ë¿ä¾à In order to respond to cybersecurity vulnerabilities that may occur in postmarket medical devices, this standard presents cybersecurity vulnerability response activities that medical device manufacturers should perform after marketing medical devices by categorizing them into monitoring, vulnerability remediation, information sharing, and end of support stages.
±¹Á¦Ç¥ÁØ
°ü·ÃÆÄÀÏ TTAK.KO-12.0381.pdf TTAK.KO-12.0381.pdf            

ÀÌÀü
¹Ì·¡ Á¤º¸Åë½Å¸Á°ú ¼­ºñ½º¸¦ À§ÇÑ Á¤º¸Åë½Å ½Ã½ºÅÛ ±â´É±¸Á¶
´ÙÀ½
GII:»óÈ£¿¬µ¿À» À§ÇÑ ÂüÁ¶Á¡